HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

isodihydrocapsiate

an LKB1-mediated AMPK activator; structure in first source

Also Known As:

8-methylnonanoic acid 3-hydroxy-4-methoxy benzyl ester

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Huh, Tae-Lin: 1 article (06/2008)
2.	Hwang, Seung-Lark: 1 article (06/2008)
3.	Kim, Byung-Dong: 1 article (06/2008)
4.	Kim, Byung-Hong: 1 article (06/2008)
5.	Kim, Dae Young: 1 article (06/2008)
6.	Kim, Dae-Yong: 1 article (06/2008)
7.	Kim, Jeong-Han: 1 article (06/2008)
8.	Kim, Moon Sung: 1 article (06/2008)
9.	Lee, Jai-Youl: 1 article (06/2008)
10.	Park, Byeoung-Soo: 1 article (06/2008)

Related Diseases

1.

Type 2 Diabetes Mellitus (MODY)

06/27/2008 - "Our results support the development of isodihydrocapsiate as a potential therapeutic agent to target AMPK in type 2 diabetes."
06/27/2008 - "We report that a synthetic structural isomer of dihydrocapsiate, isodihydrocapsiate (8-methylnonanoic acid 3-hydroxy-4-methoxy benzyl ester) improves type 2 diabetes by activating AMPK through the LKB1 pathway. "

Related Drugs and Biologics

1.	capsiate